Here is an ice cube you do not want to put in your Diet Coke: A solid lattice of oxygen atoms with protons whizzing around inside of it. This ice is not normal on Earth, but might be elsewhere. And scientists have created it in a lab.
Read more
Credit: University of New Mexico For years, scientists have long wrestled with the control and manipulation of light, a long-standing scientific ambition with major implications for the development of technology. With the growth in nanophotonics, scientists are making gains faster than ever exploiting structures with dimensions comparable to the wavelength of light. Scientists at The University of New Mexico studying the field of nanophotonics are developing new perspectives never seen before through their research. In turn, the understanding of these theoretical concepts is enabling physic…
Read more
Part II of the Bioquark Inc. show on Grognostics — https://www.stitcher.com/podcast/grognostics/e/53166919?autoplay=true
Dr. Aubrey de Grey, is a world-famous author and biomedical gerontologist and Chief Science Officer of the SENS Research Foundation. His acclaimed lectures worldwide, include Israel and Russia and Ted Talks.
Bill Faloon, is the highly respected author of numerous articles and books, most recently: Pharmocracy II: How Corrupt Deals and Misguided Medical Regulations Are Bankrupting America—And What to Do about It.
He is co-founder of Life Extension. — An organization in the forefront of research to induce systemic rejuvenation and age reversal.
Produced and hosted on 01-25-2018 by Richard Peritz for broadcast on ABC TV-25 and networks nationwide. Show 1050.
Summary: A new report provides good news for warding off stroke and hardening of the arteries, two diseases of aging. Combining blood-pressure-lowering drugs with cholesterol-lowering medications reduced first-time strokes by 44%, according to a report by the AHA/ASA. [This article first appeared on the website LongevityFacts.com. Author: Brady Hartman. ]
Stroke is the fifth leading cause of death in the US and a disease of aging that grows more prevalent with each birthday.
Now, a report says a new drug regimen promises to cut that risk nearly in half.
Read more
At least 200 candidates with previous careers in science, technology, engineering and math announced bids for some of the nation’s roughly 7,000 state legislature seats as of Jan. 31, according to data that 314 Action, a political action committee, shared exclusively with HuffPost.
This comes at a time when there’s only one Ph.D. scientist in Congress.
Read more
It takes an immense amount of processing power to create and operate the “AI” features we all use so often, from playlist generation to voice recognition. Lightmatter is a startup that is looking to change the way all that computation is done — and not in a small way. The company makes photonic chips that essentially perform calculations at the speed of light, leaving transistors in the dust. It just closed an $11 million Series A.
The claim may sound grandiose, but the team and the tech definitely check out. Nick Harris, Lightmatter’s CEO, wrote his thesis on this stuff at MIT, and has published in major journals like Nature Photonics several papers showing the feasibility of the photonic computing architecture.
So what exactly does Lightmatter’s hardware do?
Read more
